Trial of Diphenhydramine for Sleep in Children With Autism

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 9, 2023

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions

AutismAutism Spectrum Disorder

Interventions

DRUG

Diphenhydramine

25mg (and up to 50mg) Diphenhydramine given orally

DRUG

Placebo

Matching Placebo given orally

Trial Locations (1)

RECRUITING

Stanford University, Stanford

All Listed Sponsors

collaborator

National Institutes of Health (NIH)

NIH

lead

Stanford University

OTHER